Publications by authors named "Jan Barc"
Article Synopsis
- A study on gene therapy for critical limb ischemia used VEGF 165 plasmids, with or without stem cells, on 21 patients with thromboangiitis obliterans (TAO).
- Patients were divided into three groups: dual therapy (cells + plasmid), plasmid only, and a control group receiving saline.
- Results showed significant improvements in blood flow and pain reduction in the dual therapy group, indicating that this treatment is safe and effective.
Diabetic foot syndrome (DFS) is one of the most serious macroangiopathic complications of diabetes. The primary treatment option is revascularization, but complementary therapies are still being sought. The study group consisted of 18 patients diagnosed with ischemic ulcerative and necrotic lesions in DFS.
View Article and Find Full Text PDF